{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"31.000","rs_stock_flag":false,"fiscal_year_end":"","hist_closedate":"","replication_method":null,"amt_os":"160,701,996","primaryexch":"香港交易所","ric":"2575.HK","product_subtype":null,"db_updatetime":"2025年10月15日09:36","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":null,"inline_upper_strike_price":"","sedol":"BTXY8J6","am":"344.65","iv":"","ew_strike":"","as":"28.820","geographic_focus":null,"incorpin":"中華人民共和國","etp_baseCur":null,"ew_amt_os":"","bd":"28.720","registrar":"香港中央證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"500","update_time":"2025-10-15 01:36:30.0","lo52":"","shares_issued_date":"2025年10月15日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"徐艷君","underlying_ric":"2575.HK","hi52":"","issuer_name":"軒竹生物科技股份有限公司 - B - H股","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年10月15日10:18","aum_date":"","lo":"27.000","mkt_cap":"4.62","f_aum_hkd":null,"ew_sub_per_to":"","ls":"28.800","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"0","aum":"","issued_shares_class_B":null,"vo":"11.68","secondary_listing_flag":false,"listing_date":"2025年10月15日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"軒竹生物科技股份有限公司 - B - H股","nm_s":"軒竹生物－Ｂ","sym":"2575","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.020","strike_price":"","summary":"軒竹生物科技股份有限公司是一家主要從事生物製藥業務的中國公司。該公司主要從事研發、生產及商業化創新藥的業務，專注於消化、腫瘤和非酒精性脂肪性肝炎（NASH）等多個治療領域。該公司主要產品包括KBP-3571、XZP-3287及XZP-3621。該公司主要在中國國內和海外市場開展業務。","op":"29.460","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"中國河北省石家莊市<br/>高新區太行大街769號<br/>京津冀協作創新示範園<br/>203C507","pc":"0.00","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":null,"hdr":false,"launch_date":"","hc":"","isin":"CNE1000074Q1","moneyness":""}},"qid":"1760495613643"}
